Scenario
Business helping business. Bioprocess industries are our focus. Improving your margins is our mission. Pharma, biotechnology, agriculture, bio fuels, enzymes, food processing... fermentations, anaerobic digestions, biomass cultivation and extractions.
You are the CEO, Division President or other senior executive leader of a bioprocess entity. Your financial margins seem like they could be better. You have already cut costs to the bone. OK, so your production process design has not changed much since it was delivered from the lab. Maybe revisiting the process design would be the logical next step.
But there are so many process variables to deal with and each variable has dozens of possible values. The combinations could number in the trillions of trillions. It just doesn't make business sense to discover beneficial changes using trial and error or statistical methods. You know you would have to spend a large amount with no assurance that benefits, if any, would even cover the experimentation costs. And to cover even a few variable combinations exhaustively would likely take years of experimenting using trial and error or conventional statistical methods. And you haven't even considered the potential production disruption impacts.
Then one day a vendor shows up and offers you a way to significantly improve your bottom line through process changes based on scientific principles. He describes to you a 21st century solution combining advanced software analytics in parallel with high throughput bioprocess simulation. The vendor uses this technology to deliver bioprocess optimization services at their facilities avoiding any customer disruption.
This unique, advanced technology was developed over five years under a U.S. Department of Defense research grant. He says every possible process and business variable and value combination is evaluated, even trillions of trillions. Scientifically proven with several bioprocesses, he says they can deliver results in way less than a year, not a lifetime it would take by conventional means. Then he astounds you again... he backs it up by stating your company doesn’t owe his company a dime unless the expected financial margin enhancements are delivered and proven in production. Even then they only expect a share of the additional profit that is generated by their efforts.
Too good to be true? Or I need to know more, it's surely worth a few minutes to see what it's all about.
Find out more at our Services page including our no risk offer and our unique applied science.
| 
